133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study

Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research